The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
- PMID: 22443195
- DOI: 10.1517/14728222.2011.650632
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
Abstract
Introduction: miRNAs are noncoding RNAs that target specific mRNA with subsequent regulation of particular genes, implicated in various biological processes. In cancer, miRNAs could show a different expression from normal tissues. miRNAs have a role as oncogenes when they target tumor suppressor genes and similarly they are tumor suppressors when they target oncogenes.
Areas covered: In this review, areas covered include the role of miRNAs in cancer diagnosis, prognosis and research for achievement of therapeutic strategies implicating miRNAs in oncology. As biogenesis of miRNAs is fundamental to understand their usefulness, this has also been discussed. Both miRNA expression profiles in cancer tissues and miRNA levels in peripheral blood were studied for improvement in the management of cancer patients.
Expert opinion: miRNAs have the potential for better understanding of tumor biology, but could also provide clinical advancement in management and therapy of various malignancies. The possibility of miRNA detection in peripheral blood would allow an eager expansion of their application in various clinical settings for cancer. The applicability of miRNA expression profiles still needs to be defined.
Similar articles
-
miRNAs as molecular biomarkers of cancer.Expert Rev Mol Diagn. 2010 May;10(4):435-44. doi: 10.1586/erm.10.27. Expert Rev Mol Diagn. 2010. PMID: 20465498 Review.
-
MiRNAs as biomarkers and therapeutic targets in cancer.Curr Opin Pharmacol. 2010 Oct;10(5):543-50. doi: 10.1016/j.coph.2010.05.010. Epub 2010 Jun 10. Curr Opin Pharmacol. 2010. PMID: 20541466 Review.
-
Pre-analytical variables in miRNA analysis.Clin Biochem. 2013 Jul;46(10-11):861-8. doi: 10.1016/j.clinbiochem.2013.02.015. Epub 2013 Mar 4. Clin Biochem. 2013. PMID: 23466658 Review.
-
MicroRNAs in tumorigenesis: a primer.Am J Pathol. 2007 Sep;171(3):728-38. doi: 10.2353/ajpath.2007.070070. Am J Pathol. 2007. PMID: 17724137 Free PMC article. Review.
-
MicroRNAs as therapeutic targets and their potential applications in cancer therapy.Expert Opin Ther Targets. 2012 Aug;16(8):747-59. doi: 10.1517/14728222.2012.696102. Epub 2012 Jun 13. Expert Opin Ther Targets. 2012. PMID: 22690697 Review.
Cited by
-
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.J Transl Med. 2013 Jan 9;11:10. doi: 10.1186/1479-5876-11-10. J Transl Med. 2013. PMID: 23302469 Free PMC article.
-
Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.Cell Mol Life Sci. 2013 Apr;70(7):1207-20. doi: 10.1007/s00018-012-1121-3. Epub 2012 Aug 24. Cell Mol Life Sci. 2013. PMID: 22918484 Free PMC article. Review.
-
MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.Tumour Biol. 2016 Nov;37(11):15325-15332. doi: 10.1007/s13277-016-5444-9. Epub 2016 Oct 4. Tumour Biol. 2016. PMID: 27704356
-
Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma.Pak J Med Sci. 2019 Sep-Oct;35(5):1408-1412. doi: 10.12669/pjms.35.5.331. Pak J Med Sci. 2019. PMID: 31489016 Free PMC article.
-
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.Cancers (Basel). 2023 Jun 22;15(13):3286. doi: 10.3390/cancers15133286. Cancers (Basel). 2023. PMID: 37444397 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials